FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageus.nlm.vsac
Resource TypeValueSet
IdValueSet-2.16.840.1.113762.1.4.1151.4.json
FHIR VersionR4
Sourcehttps://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1151.4/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.4
Version20160713
Statusactive
Date2016-07-13T01:00:02-04:00
NameBCGBacillusCalmetteGuerinTice
TitleBCG Bacillus Calmette Guerin, Tice
Realmus
Authorityhl7
Purpose(Clinical Focus: BCG is used for the treatment of non muscle invasive bladder cancer and is administered intravesically),(Data Element Scope: The intent of this data element is to include BCG as a treatment for non muscle invasive bladder cancer),(Inclusion Criteria: Bacillus Calmette Guerin for intravesical use),(Exclusion Criteria: None)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1151.4",
  "meta": {
    "versionId": "3",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Oregon Urology Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-02-08"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2016-07-13"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.4",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1151.4"
    }
  ],
  "version": "20160713",
  "name": "BCGBacillusCalmetteGuerinTice",
  "title": "BCG Bacillus Calmette Guerin, Tice",
  "status": "active",
  "experimental": false,
  "date": "2016-07-13T01:00:02-04:00",
  "publisher": "Oregon Urology Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: BCG is used for the treatment of non muscle invasive bladder cancer and is administered intravesically),(Data Element Scope: The intent of this data element is to include BCG as a treatment for non muscle invasive bladder cancer),(Inclusion Criteria: Bacillus Calmette Guerin for intravesical use),(Exclusion Criteria: None)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "221050",
            "display": "BCG, Live, Tice Strain"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:9c8ae351-e734-4d0a-8fb4-dc57cd1f4fd9",
    "timestamp": "2025-05-23T18:58:44-04:00",
    "total": 1,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "221050",
        "display": "BCG, live, Tice strain"
      }
    ]
  }
}